Skip to main content
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1999 Sep;90(9):977–981. doi: 10.1111/j.1349-7006.1999.tb00844.x

Expression of Vascular Endothelial Growth Factor (VEGF) Family Members in Breast Cancer

Junichi Kurebayashi 1,, Takemi Otsuki 2, Hironori Kunisue 1, Yoshinori Mikami 3, Katsuhiko Tanaka 1, Shigeru Yamamoto 1, Hiroshi Sonoo 1
PMCID: PMC5926164  PMID: 10551327

Abstract

Vascular endothelial growth factor (VEGF)‐A is known to play an important role in tumor angiogenesis. Three additional members of the VEGF family, VEGF‐B, ‐C and ‐D, have recently been discovered. VEGF‐C and VEGF‐D are ligands for VEGF receptor‐3, which is expressed in the endothelium of lymphatic vessels. The expression of VEGF‐C is known to be associated with the development of lymphatic vessels. Therefore, it is conceivable that VEGF‐C and VEGF‐D might play a role in the development of lymphatic vessels in solid tumors. To obtain some clue as to this role, we developed a semi‐quantitative reverse transcription‐polymerase chain reaction method to investigate the mRNA expression levels of each VEGF family member in breast cancer. All the VEGF family members were expressed at different levels in seven human breast cancer cell lines explored. Although VEGF‐A and VEGF‐B expressions were detected in both node‐positive and node‐negative breast tumors, VEGF‐C expression was detected only in node‐positive tumors. VEGF‐D expression was detected only in an inflammatory breast cancer and a tumor which developed an inflammatory skin metastasis. These findings suggest a possible relationship between the expression level of VEGF‐C and/or VEGF‐D and the development of lymphatic tumor spread.

Keywords: VEGF‐C, VEGF‐D, Lymph node metastasis, nflammatory breast cancer

Full Text

The Full Text of this article is available as a PDF (229.4 KB).

REFERENCES

  • 1).Folkman , J.Angiogenesis in cancer, vascular, rheumatoid and other disease . Nat. Med. , 1 , 27 – 31 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 2).Shweiki , D. , Neeman , M. , Itin , A. and Keshet , E.Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis . Proc. Natl. Acad. Sci. USA , 92 , 768 – 772 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3).Olofsson , B. , Pajusola , K. , Kaipainen , A. , von Euler , G. , Joukov , V. , Saksela , O. , Orpana , A. , Petersson , R. F. , Alitalo , K. and Erikson , U.Vascular endothelial growth factor B, a novel growth factor for endothelial cells . Proc. Natl. Acad. Sci. USA , 93 , 2576 – 2581 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4).Joukov , V. , Pajusola , K. , Kaipainen , A. , Chilov , D. , Lahtinen , I. , Kukk , E. , Saksela , O. , Kalkkinene , N. and Alitala , K.A novel vascular endothelial growth factor, VEGF‐C, is a ligand for the Flt4 (VEGFR‐3. and KDR (VEGFR‐2. receptor tyrosine kinases . EMBO J. , 15 , 290 – 298 ( 1996. ). [PMC free article] [PubMed] [Google Scholar]
  • 5).Yamada , Y. , Nezu , J. , Shimane , M. and Hirata , Y.Molecular cloning of a novel vascular endothelial growth factor, VEGF‐D . Genomics , 42 , 483 – 488 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 6).Achen , M. G. , Jeltsch , M. , Kukk , E. , Makinen , T. , Vitali , A. , Wilks , A. F. , Alitalo , K. and Stacker , S. A.Vascular endothelial growth factor D (VEGF‐D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1. and VEGF receptor 3 (Flt4) . Proc. Natl. Acad. Sci. USA , 95 , 548 – 553 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7).Nicosia , R. F.What is the role of vascular endothelial growth factor‐related molecules in tumor angiogenesis ? Am. J. Pathol. , 153 , 11 – 16 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8).Salven , P. , Lymboussaki , A. , Heikkila , P. , Jaaskela‐Saari , H. , Enholm , B. , Aase , K. , von Euler , G. , Eriksson , U. , Alitalo , K. and Joensuu , H.Vascular endothelial growth factors VEGF‐B and VEGF‐C are expressed in human tumors . Am. J. Pathol. , 153 , 103 – 108 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9).Enholm , B. , Paavonen , K. , Ristimaki , A. , Kumar , V. , Gunji , Y. , Klefstrom , J. , Kivinen , L. , Laiho , M. , Olofsson , B. , Joukov , V. , Eriksson , U. and Alitalo , K.Comparison of VEGF, VEGF‐B, VEGF‐C and Ang‐1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia . Oncogene , 14 , 2475 – 2483 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 10).Sowter , H. M. , Corps , A. N. , Evans , A. L. , Clark , D. E. , Charnock‐Jones , D. S. and Smith , S.Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors . Lab. Invest. , 77 , 607 – 614 ( 1997. ). [PubMed] [Google Scholar]
  • 11).Jeltsch , M. M. , Kaipainen , A. , Joukov , V. , Meng , X. , Lakso , M. , Rauval , H. , Swartz , M. , Fukumura , D. , Jain , R. K. and Alitalo , K.Hyperplasia of lymphatic vessels in VEGF‐C transgenic mice . Science , 276 , 1423 – 1425 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 12).Kurebayashi , J. , Kurosumi , M. and Sonoo , H.A new human breast cancer cell line, KPL‐1, secretes tumor‐associated antigens and grows rapidly in female athymic nude mice . Br. J. Cancer , 71 , 845 – 853 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13).Kurebayashi , J. , Kurosumi , M. and Sonoo , H.A new human breast cancer cell line, KPL‐3C, secretes parathyroid hormone‐related protein and produces tumors associated with microcalcifications in nude mice . Br. J. Cancer , 74 , 200 – 207 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14).Kurebayashi , J. , Tang , C. K. , Otsuki , T. , Kurosumi , M. , Yamamoto , S. , Tanaka , K. , Mochizuki , M. , Nakamura , H. and Sonoo , H.Isolation and characterisation of a new human breast cancer cell line, KPL‐4, expressing the Erb B family receptors and interleukin‐6 . Br. J. Cancer , 79 , 707 – 717 ( 1999. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15).Pinder , S. E. , Ellis , I. O. , Galea , M. , O'Rouke , S. , Blamey , R. W. and Elston , C. W.Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long‐term follow‐up . Histopathology , 24 , 41 – 47 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 16).Fidler , I. J. and Ellis , L. M.The implications of angiogenesis for the biology and therapy of cancer metastasis . Cell , 79 , 185 – 188 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 17).Lymboussaki , A. , Partanen , T. A. , Olofsson , B. , Thomas‐Crusells , J. , Fletcher , C. D. , de Waal , R. M. , Kaipainen , A. and Alitalo , K.Expression of the vascular endothelial growth factor C receptor VEGFR‐3 in lymphatic endothelium of the skin and in vascular tumors . Am. J. Pathol. , 153 , 395 – 403 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES